These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30341797

  • 1. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
    Zhou C, Qian W, Ma J, Cheng L, Jiang Z, Yan B, Li J, Duan W, Sun L, Cao J, Wang F, Wu E, Wu Z, Ma Q, Li X.
    Cell Prolif; 2019 Jan; 52(1):e12514. PubMed ID: 30341797
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
    Zhang Z, Han H, Rong Y, Zhu K, Zhu Z, Tang Z, Xiong C, Tao J.
    J Exp Clin Cancer Res; 2018 Nov 28; 37(1):291. PubMed ID: 30486896
    [Abstract] [Full Text] [Related]

  • 3. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan 28; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 4. Gemcitabine treatment induces endoplasmic reticular (ER) stress and subsequently upregulates urokinase plasminogen activator (uPA) to block mitochondrial-dependent apoptosis in Panc-1 cancer stem-like cells (CSCs).
    Wang L, Zhang Y, Wang W, Zhu Y, Chen Y, Tian B.
    PLoS One; 2017 Jan 28; 12(8):e0184110. PubMed ID: 28854261
    [Abstract] [Full Text] [Related]

  • 5. A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer.
    Zhu SL, Qi M, Chen MT, Lin JP, Huang HF, Deng LJ, Zhou XW.
    Phytomedicine; 2024 Jun 28; 128():155377. PubMed ID: 38503154
    [Abstract] [Full Text] [Related]

  • 6. Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1.
    Wang Q, Gong M, Liu R, Mo J, Bai R, An R, Wang X, Han L, Wang Z, Ma Q, Wu Z, Zhou C.
    Phytomedicine; 2024 Jul 28; 129():155656. PubMed ID: 38723529
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
    Zhang Z, Duan Q, Zhao H, Liu T, Wu H, Shen Q, Wang C, Yin T.
    Cancer Lett; 2016 Nov 01; 382(1):53-63. PubMed ID: 27576197
    [Abstract] [Full Text] [Related]

  • 8. Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell.
    Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ, Zhang Q, Wang R, Zhang HZ.
    Cancer Chemother Pharmacol; 2008 Nov 01; 62(6):1055-64. PubMed ID: 18297287
    [Abstract] [Full Text] [Related]

  • 9. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling.
    Zhang Z, Wang F, Du C, Guo H, Ma L, Liu X, Kornmann M, Tian X, Yang Y.
    Cancer Lett; 2017 Aug 28; 402():213-224. PubMed ID: 28602977
    [Abstract] [Full Text] [Related]

  • 10. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Yin T, Zhang Z, Cao B, Duan Q, Shi P, Zhao H, Camara SN, Shen Q, Wang C.
    Oncotarget; 2016 Jun 14; 7(24):37192-37204. PubMed ID: 27177084
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.
    Chen D, Niu M, Jiao X, Zhang K, Liang J, Zhang D.
    Int J Mol Sci; 2012 Jun 14; 13(1):1186-1208. PubMed ID: 22312312
    [Abstract] [Full Text] [Related]

  • 12. Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205.
    Chaudhary AK, Mondal G, Kumar V, Kattel K, Mahato RI.
    Cancer Lett; 2017 Aug 28; 402():1-8. PubMed ID: 28536008
    [Abstract] [Full Text] [Related]

  • 13. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
    Xu BQ, Fu ZG, Meng Y, Wu XQ, Wu B, Xu L, Jiang JL, Li L, Chen ZN.
    Oncotarget; 2016 Sep 20; 7(38):62177-62193. PubMed ID: 27556697
    [Abstract] [Full Text] [Related]

  • 14. Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.
    Niess H, Camaj P, Renner A, Ischenko I, Zhao Y, Krebs S, Mysliwietz J, Jäckel C, Nelson PJ, Blum H, Jauch KW, Ellwart JW, Bruns CJ.
    Target Oncol; 2015 Jun 20; 10(2):215-27. PubMed ID: 24950733
    [Abstract] [Full Text] [Related]

  • 15. Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer.
    Yamaguchi J, Kokuryo T, Yokoyama Y, Oishi S, Sunagawa M, Mizuno T, Onoe S, Watanabe N, Ogura A, Ebata T.
    Cancer Med; 2024 Jun 20; 13(11):e7395. PubMed ID: 38872370
    [Abstract] [Full Text] [Related]

  • 16. Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.
    Yang MC, Wang HC, Hou YC, Tung HL, Chiu TJ, Shan YS.
    Mol Cancer; 2015 Oct 12; 14():179. PubMed ID: 26458814
    [Abstract] [Full Text] [Related]

  • 17. De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.
    Tadros S, Shukla SK, King RJ, Gunda V, Vernucci E, Abrego J, Chaika NV, Yu F, Lazenby AJ, Berim L, Grem J, Sasson AR, Singh PK.
    Cancer Res; 2017 Oct 15; 77(20):5503-5517. PubMed ID: 28811332
    [Abstract] [Full Text] [Related]

  • 18. Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling.
    Zou J, Su H, Zou C, Liang X, Fei Z.
    J Biochem Mol Toxicol; 2020 Jun 15; 34(6):e22480. PubMed ID: 32104955
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Notch3 enhances sensitivity to gemcitabine in pancreatic cancer through an inactivation of PI3K/Akt-dependent pathway.
    Yao J, Qian C.
    Med Oncol; 2010 Sep 15; 27(3):1017-22. PubMed ID: 19816816
    [Abstract] [Full Text] [Related]

  • 20. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
    Liu F, Liu B, Qian J, Wu G, Li J, Ma Z.
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun 01; 49(6):520-529. PubMed ID: 28459992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.